JAMJOOM PHARMA
4015TASIPharmaBiotech & Life Science
125.40SAR(2.60) (2.03%)
- Open
- 128.00
- High
- 128.00
- Low
- 125.40
- Prev. close
- 128.00
- Volume
- 28.80K
- Value
- 3.63M
- Trades
- 711
4015TASIPharmaBiotech & Life Science
| Item | 2025 | Change |
|---|---|---|
| Total revenue | 1,500.63 | 13.82% |
| Gross profit | 945.81 | 10.54% |
| Operating income | 497.56 | 16.57% |
| Net income | 463.80 | 30.09% |
| Item | 2025 | Change |
|---|---|---|
| Total assets | 2,045.56 | — |
| Total liabilities | 328.79 | — |
| Total debt | 16.43 | 684.48% |
| Shareholders’ equity | 1,716.77 | — |
| Item | 2025 | Change |
|---|---|---|
| Operating cash flow | 406.29 | 54.31% |
| Investing cash flow | (68.79) | — |
| Financing cash flow | (243.15) | (11.89%) |
| Free cash flow | 170.04 | (17.65%) |